Haryana Board Last Year Question Paper Class 12 Bio-Technology With Solutions: Haryana Board of School Education (HBSE) provides its students with previous year's question papers to strengthen their preparation and provide them with sufficient ideas related to the question paper asked in the HBSE Board Exams. Here, we have brought to you HBSE Class 12 Bio-Technology previous year's question paper in pdf form. Students who wish to save the papers can download them using the PDF download link attached below. Here, all the sets of question papers from 2023 and 2022 have been provided for your reference.
HBSE 12th Bio-Technology Previous Year Question Papers with Solutions - Download PDF
The Haryana Board Class 12 previous year question papers for 2023 and 2022 have been provided to you below. Any updates from the board authority, on the previous year's papers will be provided here immediately.
Haryana Board 12th Bio-Technology Previous Year Question Papers with Solutions |
Haryana Board Class 12 Bio-Technology Marking Scheme (2023 - 2024)
The marking scheme has been provided in the table below for all the students of the 2023-204 batch. This will assist you in performing well and most importantly preparing well for the exam.
Type of Question | No. of Questions | Total Marks |
MCQ Questions | 15 | 15 x 1 = 15 |
Very Short Answer Type | 6 | 6 x 2 = 12 |
Short Answer Type | 6 | 6 x 3 = 18 |
Long Answer Type | 5 | 5 x 3 = 15 |
Why should one solve HBSE 12th Bio-Technology Previous Year’s Question Papers?
HBSE 12th Bio-Technology Previous Year’s Question Papers should be solved because of the following reasons:
- Previous Year's Question Papers inform students about the types and typology of questions
- It informs students about the frequently repeated questions and which form of question has a high tendency of coming in exam
- The ability to solve the question from the previous year's papers boosts the confidence of students
- Familiarises students with the examination and question paper as a whole
Also Read:
Comments
All Comments (0)
Join the conversation